Otros idiomas Sio Gene Therapies Börse Stuttgart

Acciones

6YY

US8293991043

Diferido Börse Stuttgart Otros sitios de cotización			Varia. Cinco días.	Varia. 1 de enero.
- ^EUR	-.--%		-1,65 %	-16,01 %

2023	Sio Gene Therapies Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 31 de diciembre de 2022	CI
2022	El consejo de Sio Gene Therapies aprueba un plan de liquidación y disolución; las acciones suben después de hora	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02/02
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02/02
SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	06/04/23
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index	27/03/23
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index	22/03/23
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	15/03/23
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	15/03/23
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	14/02/23
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/02/23
Sio Gene Therapies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23
Sio Gene Therapies Board Approves Plan of Liquidation, Dissolution; Shares Rise After Hours	14/12/22
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution	14/12/22
Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K	14/12/22
SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)	14/12/22
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/11/22
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/22
Sio Gene Therapies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results	10/11/22
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	14/09/22
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	14/09/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Sio Gene Therapies Börse Stuttgart

Acciones

6YY

US8293991043

Otros idiomas

Filtros